Rather than waiting for the start of the new year to establish weight loss objectives, an increasing number of individuals are starting their weight loss efforts using popular drugs as early as autumn.
Experts claim that gaining weight during the holidays can take a long time to shed, but embracing positive routines and beginning a weight loss medicationPlanning in advance can assist in making better decisions during the season, which can ultimately encourage weight loss.
Studies indicate that it's much simpler to prevent holiday weight gain from the start rather than trying to shed it once it has occurred.
As autumn arrives, it marks a return to a consistent and stable routine that tends to be neglected during the summer months. Medical professionals note that this period encourages a reassessment of habits and healthy practices that can motivate individuals tolose weight, which could involve using one of the innovative weight loss medications, like Wegovy or Zepbound.
Combining drugs with positive lifestyle habits enhancesthe already impressive amountThe amount of weight individuals can shed using these medications is influenced by establishing a calorie deficit, preserving muscle tissue, and controlling adverse effects such as nausea and swelling.
Numerous individuals embrace what specialists have referred to as the 'October theory' since they failed to shed the desired amount of weight prior to summer and aim to conclude the year with a more uplifting outlook.
Medical professionals state that methods to increase the weight loss during this fall do not need to significantly interfere with one's daily routine.
They involve consuming more well-rounded meals and preparing food at home, discovering an activity they like and can maintain several times a week, and consulting with a dietitian, which is often included in many insurance plans.
In the United States, approximately 70 percent of adult Americans, which equates to around 180 million individuals, are classified as overweight or obese, with 43 percent, roughly 112 million adults, falling into the category of obesity.
A 2024 study revealed that one out of every eight American adults has used a GLP-1 medication, with six percent stating they are currently on such a drug.
Numerous individuals shed 10% or more of their body weight within approximately six months, although the medications carry troubling side effects such as vomiting, loose stools, and stomach discomfort.
Studies conducted since the drug became available four years ago have also revealed that individuals who discontinue the medication often quickly regain the weight they had lost, as their appetite, which had been previously controlled by the drug, returns.
A 2022 research tracked GLP-1 users over a period of two years. Individuals who discontinued semaglutide, a form of GLP-1, experienced a notable weight regain, concluding with an averagea decrease of just 5.6 percent. Conversely, the placebo group experienced nearly no change in weight, resulting in a minimal loss of 0.1 percent.
Dr. Holly Lofton, an obesity medicine specialist at NYU Langone Hospital, said to the New York Post: 'For individuals thinking about or currently using GLP-1 drugs, combining them with updated lifestyle approaches during this "reset season" can enhance their effectiveness.'
By using October as a base for developing healthier habits and ensuring the necessary resources are available to handle challenges, individuals can set themselves up for sustained health benefits.
The October theory generates a mix of nervousness and drive, much like the emotions experienced at the beginning of a new year. It encourages a time for introspection regarding one's achievements and future objectives.
Lofton also suggested that individuals monitor their development throughout the holiday period using a journal or a fitness application, which may boost motivation when the urge to overeat arises.
She stated: "It is essential to plan carefully for these gatherings and meals, making sure to limit overeating of fatty foods, especially fried items and large portions of cheese, particularly when consumed alongside alcohol."
Initiating drug therapy at this point may help in reducing hunger and urges.
Monthly sales data for weight loss medications such as Ozempic, Wegovy, Zepbound, and Mounjaro is not disclosed to the public.
However, a research project carried out by Optum, the prescription drug division of UnitedHealth, revealed that individuals are more inclined to begin and renew prescriptions for weight-loss medications during the colder seasons.
The use of these medications increased by 18.1 percent, and refills rose by 38.2 percent during the fall and winter months in comparison to spring and summer.
A recurring pattern was noted among all age groups and both sexes, with males showing a greater fluctuation compared to females.
In total, the rate of prescriptions has risen by 400 percent since these drugs became available in 2021.
GLP-1 drugs function by minimizing 'food noise,' which refers to the ongoing mental focus on eating that complicates calorie restriction.
By suppressing this persistent desire to eat, the medications help people lower their calorie consumption.
The medications imitate a hormone in the body that transmits signals to the brain indicating satiety.
GLP-1s also decrease the speed at which food exits the stomach, extending the sensation of satiety and minimizing the desire to eat again shortly after a meal.
Initiating a GLP-1 medication before or during the holiday period may assist in controlling hunger and desires, offering assistance during a time marked by greater temptation and indulgent food and sweets.
At present, over half of American adults express a desire to shed pounds, yet only 27 percent are taking action via diet, physical activity, and/or medical treatments.
Read more- Can your weight loss objectives be enhanced by a high-fiber diet that stimulates GLP-1, the hormone targeted by leading weight-loss medications such as Ozempic?
- Could the emergence of weight-loss medications such as Ozempic change our perception of hunger and improve the lives of those struggling with constant food-related thoughts?
- Is the emergence of Ozempic and comparable medications offering new optimism in the fight against obesity?
- Could Andrea Marcellus's GLP-1 enhancing diet be the breakthrough for avoiding Ozempic injections and their uncomfortable side effects?
- Is Ro's innovative GLP-1 Insurance Tool the key to transforming your weight loss experience with Ozempic, Wegovy, and Zepbound?
Posting Komentar